WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 38 filers reported holding WEREWOLF THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,405 | -41.3% | 2,100 | -50.0% | 0.00% | – |
| Q1 2023 | $10,920 | -99.3% | 4,200 | -98.8% | 0.00% | – |
| Q3 2022 | $1,520,000 | -28.4% | 337,073 | -35.0% | 0.00% | – |
| Q2 2022 | $2,122,000 | -7.0% | 518,772 | +0.0% | 0.00% | – |
| Q1 2022 | $2,282,000 | -48.3% | 518,635 | +39.9% | 0.00% | – |
| Q4 2021 | $4,415,000 | +7.9% | 370,734 | +55.4% | 0.00% | – |
| Q3 2021 | $4,093,000 | -25.5% | 238,500 | -24.3% | 0.00% | – |
| Q2 2021 | $5,494,000 | – | 315,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $10,274,000 | 48.81% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $74,716,000 | 13.89% |
| MPM BioImpact LLC | 2,388,011 | $41,647,000 | 6.84% |
| Soleus Capital Management, L.P. | 563,396 | $9,826,000 | 1.51% |
| RA Capital Management | 4,291,881 | $74,850,000 | 1.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 706,294 | $12,049,000 | 0.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,552,787 | $44,521,000 | 0.79% |
| Nicholas Investment Partners, LP | 294,654 | $5,139,000 | 0.32% |
| Avidity Partners Management LP | 650,265 | $11,341,000 | 0.31% |
| PFM Health Sciences, LP | 400,000 | $6,976,000 | 0.22% |